ZANTE GREG (Chief Financial Officer) received a stock award from VIKING THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/27/2024ACC: 0001209191-24-005116
Officer· Chief Financial Officer
Since Jan 2021
+15.06K
Net shares
Net buyer
$1.38M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
31.67K acquired · 16.61K disposed
Non-Derivative Transactions2
Common Stock, par value $0.00001 per share
Direct
Shares
+31.67K
Price / share
—
Trade value
—
% of position
16.5%
3/27/2024
192.30K→223.97K
Common Stock, par value $0.00001 per share
Direct
Shares
−16.61K
Price / share
$83.34
Trade value
$1.38M
% of position
7.4%
3/27/2024
223.97K→207.36K
Total
Net shares
+15.06K
Net value
-$1.38M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 3/27/2024 | A · Award | +31.67K | — | — | 16.5% | 192.30K | 223.97K |
| Common Stock, par value $0.00001 per share Direct | 3/27/2024 | F · Tax Withholding | −16.61K | $83.34 | $1.38M | 7.4% | 223.97K | 207.36K |
| Total | +15.06K | -$1.38M | ||||||
Derivative Transactions0
No derivative transactions reported